ARCHIVES

FDA Grants Priority Review To Two Drugs in NSCLC

This article is from The Cancer Letter archive.

Vol. 36 No. 2 | February 22, 2013

Download PDF Visit The Full Archive

Related Articles

Sam Broder Receives Arthur Flemming Award

June 1, 1984

Grantees Not In Danger Of Losing Cost-Free Biological Materials, But Can’t Have Chemicals

September 9, 1977

In Phase II Study, NKTR-102 Shows Objective Response

January 28, 2011

Kennedy Bills Would Authorize Senior Scientist Service, New Foundation, Construction Grants

July 28, 1989

NIH Priority To Pay 4,000 Grants, Send Summary Statements

February 2, 1996

FDA Approves Iressa For Third-Line Treatment Of Non-Small Cell Lung Cancer

May 9, 2003